BC Platforms recognized among TIME’s World’s Top HealthTech Companies 2026
BC Platforms has been recognized among TIME’s World’s Top HealthTech Companies 2026 in AI & Data Analytics for the second consecutive year.
BC Platforms has been recognized among TIME’s World’s Top HealthTech Companies 2026 in AI & Data Analytics for the second consecutive year.
A look at building rare disease evidence across countries and data sources when no established registry or natural history dataset exists.
BC Platforms has been recognized as one of the Top AWS Partners to Watch in 2026 by CIO Times.
BC Platforms launches the BC Mosaic App Store, a certified ecosystem of analytics, AI, and research applications within its TRE.
Mukhtar Ahmed discusses how AI, real-world data, and federated analytics could accelerate the shift to personalized research.
BC Platforms has been recognized by Pharma Tech Outlook Europe for leadership in evidence generation and AI-enabled drug development.
A new article by Narasimha Kumar, published in MedCity News, explores why “AI in drug development is not a data problem, it’s an evidence problem.” The article examines how the challenge is no longer collecting data, but preserving the context, meaning, and relationships that transform data into usable evidence. Kumar argues that AI cannot reliably
AI readiness in pharma depends on data, not just AI. Read how real‑world data and interoperability enable scalable evidence generation.
Federated learning with the Flower Framework is available within BC Platforms’ trusted research environments.
For press and media inquiries, contact our communications team at media@bcplatforms.com.
For partnerships, business opportunities, and all other inquiries, please fill out this form